The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.
The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.
Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.
“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”
Doctors in Taiwan made a surprising discovery when a 64-year-old female patient complained of a clicking and rustling sound in her ear, which turned out to be a spider.
Many DNA tests on the market offer a glimpse into what makes your individual character, including who your ancestors are and some can even analyze your risk for developing certain diseases. Cheddar News spoke with Sam Beeler, chief strategy officer with Nebula Genomics; Eleanor Griffith, a certified genetic counselor; and Dr. Neil Iyengar, a medical oncologist with Memorial Sloan Kettering Cancer Center about the process involved in checking DNA and its effectiveness.
A new study in the Journal of Clinical Psychiatry that involved 80 participants with moderate to severe depression found hot yoga could have some positive impacts on mental health.
